Tag Archives: Allergan Biocell
-
-
FDA Issues Final Guidance On Breast Implant Illness and BIA-ALCL Warnings
-
Allergan Biocell Lawsuit Claims Company Abandoned Implant Recipients After Cancer Recall
-
Allergan Breast Implant Lawsuit Filed Over Malignant Lymphoma Diagnosis
-
FDA Reports 733 Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Cases Identified
-
Lawsuit Filed Over Breast Implant Removal After Defective Design Recalled Due to Cancer Risk
-
Allergan’s McGhan Breast Implants Led To BIA-ALCL Diagnosis, Lawsuit Claims
-
Allergan Seeks to Avoid Liability for Problems from Recalled Breast Implants
-
Allergan Failed To Properly Report Breast Implant Lymphoma Cases To FDA, Lawsuit Claims
-
Allergan Withheld Breast Implant Lymphoma Risk Information From Public, FDA, Lawsuit Claims